Mission Pharmacal Trademark Details
Word Mark | Mission Pharmacal |
---|---|
Status | Alive Registered 800 — Registered and Renewed |
Current Owner
Mission Pharmacal Company of San Antonio, TX
View all trademarks for Mission Pharmacal CompanySerial Number | 75338602 |
---|---|
Registration Number | 2189371 |
Status Date | Friday, August 29, 2008 |
Filing Date | Friday, August 29, 2008 |
Registration Date | Tuesday, September 15, 1998 |
Attorney | Pamela B. Huff |
Correspondent
Pamela B. Huff
Cox Smith Matthews Incorporated
112 East Pecan Street Suite 1800
San Antonio TX 78205
Cox Smith Matthews Incorporated
112 East Pecan Street Suite 1800
San Antonio TX 78205
Case File Statements
Disclaimer with Predetermined Text | "Pharmacal" |
---|---|
Goods & Services | pharmaceutical products, namely, prophylactic drugs preventing calcium absorption by the human body, therapeutic multivitamin combinations, orally administered dietary supplements of calcium salt, orally administered dietary supplements of calcium salt with vitamin D, laxatives, analgesic preparations for internal use or topical application, antacid tablets for gastric hyperacidity, antispasmodic treatments, hematinic tablets of ferrous gluconate, therapeutic flouride, folic acid tablets, preparations for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalance, orally administered sodium salt tablets, high carbohydrate protein dietary food supplements, preparations for the treatment of secondary anemia, pharmaceutical preparations in chewable tablet dosage form, namely, antispasmodic, anticholinergics, antacids, antihistamines, antibiotics, antiasmatics and antinauseas, for dietary supplements as a magnesium and citrate inhibitor indicated as prophylactic for recurring kidney stones, for surgical lubricating jelly, vitamin and mineral preparations in liquid tablet and capsule form, slow-release salt tablets, prophylactic and treatment drug of potassium citrate embodied in slow-release wax matrix to prevent or dissolve kidney stones, orally administered potassium phosphate preparations utilized for treatment of kidney stones, pharmacuetical products prepared as an appetite depressant |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, September 2, 1997 |
First Use Anywhere | Monday, January 1, 1996 |
First Use In Commerce | Monday, January 1, 1996 |
Primary Code | 005 |
Trademark Timeline
-
Jan 01 1996First use anywhere for the mark
-
Jan 01 1996First use in commerce for the mark
-
Aug 11 1997Trademark application filed with USPTO
-
Mar 19 1998Assigned To Examiner
-
Mar 23 1998Assigned To Examiner
-
Mar 23 1998Assigned To Examiner
-
Apr 06 1998Examiner's Amendment Mailed
-
Apr 10 1998Approved For Pub - Principal Register
-
May 22 1998Notice of Publication
-
Jun 23 1998Published For Opposition
-
Sep 15 1998Registered-Principal Register
-
Sep 15 1998Trademark officially registered with the USPTO
-
Nov 07 2002Paper Received
-
Nov 21 2003Teas Change of Correspondence Received
-
Jul 19 2004Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
-
Jul 19 2004Teas Section 8 & 15 Received
-
Aug 23 2004Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
-
Aug 21 2008Teas Section 8 & 9 Received
-
Aug 28 2008Assigned To Paralegal
-
Aug 29 2008Registered and Renewed (first Renewal - 10 Yrs)
-
Aug 29 2008Registered - Sec. 8 (10-Yr) Accepted/sec. 9 Granted
-
Apr 18 2011Case File In Ticrs
-
May 16 2011Case File In Ticrs